207 related articles for article (PubMed ID: 20644549)
1. Morin exerts neuroprotective actions in Parkinson disease models in vitro and in vivo.
Zhang ZT; Cao XB; Xiong N; Wang HC; Huang JS; Sun SG; Wang T
Acta Pharmacol Sin; 2010 Aug; 31(8):900-6. PubMed ID: 20644549
[TBL] [Abstract][Full Text] [Related]
2. FTY720 Inhibits MPP
Yao S; Li L; Sun X; Hua J; Zhang K; Hao L; Liu L; Shi D; Zhou H
J Neuroimmune Pharmacol; 2019 Sep; 14(3):478-492. PubMed ID: 31069623
[TBL] [Abstract][Full Text] [Related]
3. Simvastatin inhibits the activation of p21ras and prevents the loss of dopaminergic neurons in a mouse model of Parkinson's disease.
Ghosh A; Roy A; Matras J; Brahmachari S; Gendelman HE; Pahan K
J Neurosci; 2009 Oct; 29(43):13543-56. PubMed ID: 19864567
[TBL] [Abstract][Full Text] [Related]
4. Neuroprotective effects of the novel D3/D2 receptor agonist and antiparkinson agent, S32504, in vitro against 1-methyl-4-phenylpyridinium (MPP+) and in vivo against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a comparison to ropinirole.
Joyce JN; Presgraves S; Renish L; Borwege S; Osredkar T; Hagner D; Replogle M; PazSoldan M; Millan MJ
Exp Neurol; 2003 Nov; 184(1):393-407. PubMed ID: 14637109
[TBL] [Abstract][Full Text] [Related]
5. Toxic effects of MPP(+) and MPTP in PC12 cells independent of reactive oxygen species formation.
Fonck C; Baudry M
Brain Res; 2001 Jun; 905(1-2):199-206. PubMed ID: 11423095
[TBL] [Abstract][Full Text] [Related]
6. D-deprenyl protects nigrostriatal neurons against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurotoxicity.
Muralikrishnan D; Samantaray S; Mohanakumar KP
Synapse; 2003 Oct; 50(1):7-13. PubMed ID: 12872288
[TBL] [Abstract][Full Text] [Related]
7. Neuroprotective effects of Eucommia ulmoides Oliv. and its bioactive constituent work via ameliorating the ubiquitin-proteasome system.
Guo H; Shi F; Li M; Liu Q; Yu B; Hu L
BMC Complement Altern Med; 2015 May; 15():151. PubMed ID: 25994206
[TBL] [Abstract][Full Text] [Related]
8. Anti-apoptotic effect of modified Chunsimyeolda-tang, a traditional Korean herbal formula, on MPTP-induced neuronal cell death in a Parkinson's disease mouse model.
Li H; Park G; Bae N; Kim J; Oh MS; Yang HO
J Ethnopharmacol; 2015 Dec; 176():336-44. PubMed ID: 26593210
[TBL] [Abstract][Full Text] [Related]
9. Melatonin enhances L-DOPA therapeutic effects, helps to reduce its dose, and protects dopaminergic neurons in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice.
Naskar A; Prabhakar V; Singh R; Dutta D; Mohanakumar KP
J Pineal Res; 2015 Apr; 58(3):262-74. PubMed ID: 25626558
[TBL] [Abstract][Full Text] [Related]
10. Neuroprotective effects of total flavonoid fraction of the Epimedium koreanum Nakai extract on dopaminergic neurons: In vivo and in vitro.
Wu L; Du ZR; Xu AL; Yan Z; Xiao HH; Wong MS; Yao XS; Chen WF
Biomed Pharmacother; 2017 Jul; 91():656-663. PubMed ID: 28494419
[TBL] [Abstract][Full Text] [Related]
11. Squamosamide derivative FLZ protects dopaminergic neurons against inflammation-mediated neurodegeneration through the inhibition of NADPH oxidase activity.
Zhang D; Hu X; Wei SJ; Liu J; Gao H; Qian L; Wilson B; Liu G; Hong JS
J Neuroinflammation; 2008 May; 5():21. PubMed ID: 18507839
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of L-deprenyl on MPP+- and MPTP-induced dopamine overflow in microdialysates of striatum and nucleus accumbens.
Wu WR; Zhu ZT; Zhu XZ
Life Sci; 2000 Jun; 67(3):241-50. PubMed ID: 10983868
[TBL] [Abstract][Full Text] [Related]
13. Tanshinone I selectively suppresses pro-inflammatory genes expression in activated microglia and prevents nigrostriatal dopaminergic neurodegeneration in a mouse model of Parkinson's disease.
Wang S; Jing H; Yang H; Liu Z; Guo H; Chai L; Hu L
J Ethnopharmacol; 2015 Apr; 164():247-55. PubMed ID: 25666429
[TBL] [Abstract][Full Text] [Related]
14. Activation of transcription factor MEF2D by bis(3)-cognitin protects dopaminergic neurons and ameliorates Parkinsonian motor defects.
Yao L; Li W; She H; Dou J; Jia L; He Y; Yang Q; Zhu J; Cápiro NL; Walker DI; Pennell KD; Pang Y; Liu Y; Han Y; Mao Z
J Biol Chem; 2012 Oct; 287(41):34246-55. PubMed ID: 22891246
[TBL] [Abstract][Full Text] [Related]
15. Neuroprotective effects of (+/-)-kavain in the MPTP mouse model of Parkinson's disease.
Schmidt N; Ferger B
Synapse; 2001 Apr; 40(1):47-54. PubMed ID: 11170221
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic effect of a novel anti-parkinsonian agent zonisamide against MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) neurotoxicity in mice.
Yokoyama H; Yano R; Kuroiwa H; Tsukada T; Uchida H; Kato H; Kasahara J; Araki T
Metab Brain Dis; 2010 Jun; 25(2):135-43. PubMed ID: 20424905
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic effect of a novel anti-parkinsonian agent zonisamide against MPTP (1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine) neurotoxicity in mice.
Yokoyama H; Yano R; Kuroiwa H; Tsukada T; Uchida H; Kato H; Kasahara J; Araki T
Metab Brain Dis; 2010 Sep; 25(3):305-13. PubMed ID: 20957419
[TBL] [Abstract][Full Text] [Related]
18. In vitro dopaminergic neuroprotective and in vivo antiparkinsonian-like effects of Delta 3,2-hydroxybakuchiol isolated from Psoralea corylifolia (L.).
Zhao G; Zheng XW; Qin GW; Gai Y; Jiang ZH; Guo LH
Cell Mol Life Sci; 2009 May; 66(9):1617-29. PubMed ID: 19322517
[TBL] [Abstract][Full Text] [Related]
19. Attenuation of MPTP/MPP(+) toxicity in vivo and in vitro by an 18-mer peptide derived from prosaposin.
Gao HL; Li C; Nabeka H; Shimokawa T; Saito S; Wang ZY; Cao YM; Matsuda S
Neuroscience; 2013 Apr; 236():373-93. PubMed ID: 23321539
[TBL] [Abstract][Full Text] [Related]
20. Guanosine exerts neuroprotective effects by reversing mitochondrial dysfunction in a cellular model of Parkinson's disease.
Li DW; Yao M; Dong YH; Tang MN; Chen W; Li GR; Sun BQ
Int J Mol Med; 2014 Nov; 34(5):1358-64. PubMed ID: 25174304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
